VitrenASE

VitrenASE Uses, Dosage, Side Effects, Food Interaction and all others data.

VitrenASE was developed by ItherX Pharmaceuticals of San Diego. In preclinical studies, companyl has shown that VitrenASE inhibits the growth of cells taken from multiple keloid biopsies as compared to the same keloidal cells treated with a control. It is believed that similar effects would be seen in cells isolated from hypertrophic scars.

Table Of contents

• VitrenASE
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	VitrenASE
Generic	VIT-100
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in diabetic retinopathy, scar tissue, and vitreous hemorrhage.

How VitrenASE works

VitrenASE is used for Proliferative Vitreoretinopathy (PVR), a serious eye disease characterized by uncontrolled cellular growth that can lead to retinal detachment and ensuing vision loss. It is expected to reduce the incidence of repeat retinal detachment in patients who undergo surgical repair.

Innovators Monograph

You find simplified version here VitrenASE